Overexpression of interleukin-15 protects against Escherichia coli-induced shock accompanied by inhibition of tumor necrosis factor-alpha-induced apoptosis
- PMID: 12717626
- DOI: 10.1086/374643
Overexpression of interleukin-15 protects against Escherichia coli-induced shock accompanied by inhibition of tumor necrosis factor-alpha-induced apoptosis
Abstract
Interleukin (IL)-15, a potent inhibitor of tumor necrosis factor (TNF)-alpha-mediated apoptosis, causes multiple organ failure during endotoxic shock. We investigated the potential role of IL-15 in protection against Escherichia coli-induced shock by using IL-15 transgenic (Tg) mice. These mice were resistant to an otherwise lethal challenge with E. coli, although bacterial burden and serum levels of TNF-alpha were similar in non-Tg mice. Apoptosis in cells of the peritoneal cavity, liver, spleen, or lung was significantly suppressed in IL-15 Tg mice after E. coli infection. Peritoneal cells from naive IL-15 Tg mice were also resistant to TNF-alpha-induced apoptosis in vitro, and neutralization of endogenous IL-15 significantly aggravated TNF-alpha-induced apoptosis. Exogenous IL-15 prevented TNF-alpha-induced apoptosis in normal mice in vitro and improved the survival rate after E. coli challenge. These results suggest that IL-15 overexpression can prevent TNF-alpha-induced apoptosis and protect against E. coli-induced shock, indicating a possible therapeutic application of IL-15 for septic shock.
Similar articles
-
Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice.J Immunol. 1990 Dec 15;145(12):4185-91. J Immunol. 1990. Retraction in: J Immunol. 1992 Mar 15;148(6):1968. PMID: 2124237 Retracted.
-
Prostaglandin E(1) protects against liver injury induced by Escherichia coli infection via a dominant Th2-like response of liver T cells in mice.Hepatology. 1999 Dec;30(6):1464-72. doi: 10.1002/hep.510300606. Hepatology. 1999. PMID: 10573526
-
Prostaglandin E2 protects against liver injury after Escherichia coli infection but hampers the resolution of the infection in mice.J Immunol. 1998 Sep 15;161(6):3019-25. J Immunol. 1998. PMID: 9743366
-
Inhibition of and sensitization to the lethal effects of tumor necrosis factor.J Inflamm. 1995-1996;47(1-2):18-26. J Inflamm. 1995. PMID: 8913926 Review.
-
Biology of proinflammatory cytokines and their antagonists.Crit Care Med. 1994 Jul;22(7):S3-7. Crit Care Med. 1994. PMID: 8026189 Review.
Cited by
-
The role of Interleukin 15 in protein degradation in skeletal muscles in rats of chronic obstructive pulmonary disease.Int J Clin Exp Med. 2015 Feb 15;8(2):1976-84. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 25932126 Free PMC article.
-
Overexpression of interleukin-15 compromises CD4-dependent adaptive immune responses against herpes simplex virus 2.J Virol. 2009 Jan;83(2):918-26. doi: 10.1128/JVI.01282-08. Epub 2008 Nov 12. J Virol. 2009. PMID: 19004955 Free PMC article.
-
Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo.J Immunol. 2006 Nov 1;177(9):6072-80. doi: 10.4049/jimmunol.177.9.6072. J Immunol. 2006. PMID: 17056533 Free PMC article.
-
Interleukin-15 and NK1.1+ cells provide innate protection against acute Salmonella enterica serovar Typhimurium infection in the gut and in systemic tissues.Infect Immun. 2009 Jan;77(1):214-22. doi: 10.1128/IAI.01066-08. Epub 2008 Nov 17. Infect Immun. 2009. PMID: 19015253 Free PMC article.
-
Beneficial metabolic activities of inflammatory cytokine interleukin 15 in obesity and type 2 diabetes.Front Med. 2015 Jun;9(2):139-45. doi: 10.1007/s11684-015-0377-z. Epub 2014 Dec 15. Front Med. 2015. PMID: 25511621 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous